Samsrita Labs Ltd.

16.65 -0.57 ▼-3.3%

23 February 2024, 04:01:00 PM
Volume: 1,259

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.drhlsl.com
Market Cap 24.83 Cr.
Enterprise Value(EV) 27.00 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.48 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 71.22 Trailing Twelve Months Ending 2023-03
Book Value / Share 8.45 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.98 Calculated using Price: 16.77
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.48 Cr. 14,808,706 Shares
FaceValue 10
About Samsrita Labs Ltd.
Dr Habeebullah Life Sciences with its group Companies has established platforms in the areas of Stem Cell Research and Therapy, New Drug Discovery, Molecular Prognosis and Diagnostics services, CRO, Stem Cell focused Super Specialty Hospital, RNA Interference Technology and Medical Devices.

Samsrita Labs Ltd. Delivery

Delivered Qty
Traded Qty

Samsrita Labs Ltd. Performance

1 Day
-3.31%
1 Week
-3.14%
1 Month
-2.57%
3 Month
+2.21%
6 Month
+1.28%
1 Year
-36.45%
2 Year
-46.55%
5 Year
-51.95%
10 Year

Samsrita Labs Ltd. Fundamental Ratios

7 years 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -16.62 -11.85 -21.62 -16.88 -6.71 12.29 -5.48
Return on Capital Employed (%) -4.07 -6.81 -12.27 -10.1 -4.53 10.2 -4.61
Return on Assets (%) -6.9 -5.06 -9.63 -7.4 -3.47 8.89 -4.32

Samsrita Labs Ltd. Balance Sheet

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 8 11 12 12 11 13 13
Non Curr. Liab. 0 0 0 0 0 0 0
Curr. Liab. 7 7 10 12 5 4 3
Minority Int. 4 4 4 4
Equity & Liab. 19 23 26 28 17 17 16
Non Curr. Assets 16 18 20 21 10 10 10
Curr. Assets 3 4 6 7 7 7 6
Misc. Exp. not W/O
Total Assets 19 23 26 28 17 17 16

Samsrita Labs Ltd. Profit and Loss

Particulars 8 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2021-09 Rs. Cr. TTM 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 1 1 2 1 0 0 0
Other Income 0 0 0 0 0 0 2 0
Total Income 1 1 2 2 0 0 2 0
Total Expenditure -2 -2 -4 -4 -1 0 0 -1
PBIDT -1 -1 -2 -2 -1 0 2 -1
Interest 0 0
Depreciation 0 0 0 0 0 0 0
Taxation -1 0 0 0 0
Exceptional Items
PAT -1 -1 -2 -2 -1 0 2 -1
Minority Interest 0 0 0 0
Share Associate 0
Other Related Items
Consolidated Net Profit -1 -1 -2 -2 -1 0 1 -1
Adjusted EPS -1 -1 -2 -1 -1 0 1 0

Samsrita Labs Ltd. Cash Flow

Particulars 7 years 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 -3 -3 -1 0 0 1
Cash Fr. Inv. -1 -1 -2 -1 0
Cash Fr. Finan. 1 5 4 2 1 0 -1
Net Change 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0

Samsrita Labs Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 58.27 52.87 52.87 52.87 52.87 52.87 52.87 52.87 52.87
Public 41.73 47.13 47.13 47.13 47.13 47.13 47.13 47.13 47.13
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Samsrita Labs Ltd. Announcements

Wed, 21 Feb 2024
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on February 21 2024 for Krishnam Raju Kalidindi
Thu, 01 Feb 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
newspaper ad
Wed, 31 Jan 2024
Results For The Quarter Ended 31.12.2023
Results for the quarter ended 31.12.2023

Samsrita Labs Ltd. Technical Scans

Fri, 23 Feb 2024
Opening at High Opening at High
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
Close Entering 52 Week Low Zone Close Entering 52 Week Low Zone

Samsrita Labs Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 374,572.18 1,560.95 +0.2%
Cipla Ltd. 118,375.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. 107,511.08 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. 97,345.81 6,742.15 -0.4%
Divi's Laboratories Ltd. 96,748.70 3,636.05 -0.3%
Zydus Lifesciences Ltd. 93,335.34 922.10 +1.9%
Torrent Pharmaceuticals Ltd. 88,913.00 2,627.10 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 42.06 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 31.92 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.56 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.33 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 69.96 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.39 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.51 2,627.10 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 6.00 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-12 4.57 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 4.00 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.42 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.80 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.43 2,627.10 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,627.10 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,627.10 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,560.95 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.20 +0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,445.00 +1.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,742.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,636.05 -0.3%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 922.10 +1.9%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,627.10 +0.7%

Samsrita Labs Ltd. FAQ's

What is Samsrita Labs share price?

Can I buy Samsrita Labs shares now?

What is the Market Cap of Samsrita Labs?

What are the key metrics to analyse Samsrita Labs?

What is the 52 Week High and Low of Samsrita Labs?

What is the trend of Samsrita Labs share price?